Exclusive agreement in North America marks first line of vascular access dressings from CareFusion<br />
<br />
CHICAGO – Vancive Medical Technologies™ and CareFusion Corporation (NYSE: CFN) today announced an exclusive agreement in the United States, Canada and Mexico for the licensing and distribution of Vancive's BeneHold™ Chlorhexidine Gluconate (CHG) antimicrobial Adhesive Technology for applications in vascular access.<br />
<br />
Under the agreement, CareFusion will ...This story is related to the following:Adhesives and SealantsSearch for suppliers of: Adhesives